Skip to content

Abivax

  • EN
  • FR
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
  • EN
  • FR

News & Events

Press Coverage

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019

The Wall Street Transcript

September 22, 2020

Interview with CEO and Chairman

Healio

September 4, 2020

Oral drug shows efficacy up to 2 years in refractory UC

DER AKTIONÄR

September 3, 2020

AKTIONÄR-Hot-Stock Abivax: Was für ein Comeback!

4 investors

September 3, 2020

Abivax Aktie deutlich im Plus – die Gründe

onvista Mahlzeit

September 3, 2020

Dax weiter im Vorwärtsgang – Covestro, Abivax, Nel und Curevac will keinen Einstieg von Tesla

  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 46

References available upon request.

© 2025 All rights reserved by Abivax 07/2024 Privacy and Terms of Use
Consent Preferences
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn